PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors
San Francisco, June 10, 2025 (GLOBE NEWSWIRE) —
PlushCare, a leading virtual healthcare platform, has announced a significant upgrade to its online Weight Loss Program, enabling greater access to GLP-1-based prescription treatments such as semaglutide through board-certified physicians. This development marks a critical milestone in the company's mission to provide affordable, clinically supervised weight management across the United States.
Accessible at https://plushcare.com/weight-loss/, the updated platform streamlines the process for eligible adults to consult with licensed physicians, receive lab work if necessary, and access customized treatment plans—all from the comfort of their homes.
'We're committed to making evidence-based weight loss solutions more accessible through modern telehealth,' said a PlushCare spokesperson. 'Our program is designed to connect people with experienced doctors who can evaluate eligibility for medications like GLP-1s and deliver a personalized plan that fits their health goals.'
Expanded Features for 2025
The revamped Weight Loss Program now includes: Nationwide Access to medical providers via secure telehealth appointments
to medical providers via secure telehealth appointments Eligibility Evaluation for FDA-approved medications, including semaglutide
for FDA-approved medications, including semaglutide Personalized Plans tailored to each user's metabolic profile
tailored to each user's metabolic profile Optional Lab Testing with integrated results for precision treatment
with integrated results for precision treatment Transparent Pricing with no insurance required
The platform is optimized for mobile and desktop users, offering a seamless experience from appointment scheduling to prescription delivery.
Addressing a Growing National Health Concern
According to the CDC, over 40% of U.S. adults struggle with obesity, with rising demand for effective clinical support. PlushCare's integrated virtual care model delivers a scalable solution that removes traditional geographic and scheduling barriers.
Patients can typically get started in under 15 minutes by completing an intake form and booking a same-day appointment with a licensed doctor. If clinically appropriate, a prescription is sent to their preferred pharmacy.
About PlushCare
PlushCare is a virtual primary care and mental health platform that connects patients with top U.S. medical professionals through its secure telehealth platform. With a commitment to quality care, convenience, and evidence-based treatment, PlushCare is redefining access to modern healthcare.
For more information, visit https://plushcare.com.
Media Contact:PlushCare Media Relations
Email: [email protected]
Website: https://plushcare.com
Address: 345 California Street, Suite 600, San Francisco, CA 94105, United States
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Autoimmune Collaboration and Licensing Deals Report 2025: Comprehensive Analysis of 943 Autoimmune Licensing Deals (2016-2025) Across 30+ Diseases
The 2025 report on Autoimmune Collaboration & Licensing Deals analyzes 943 agreements from 2016-2025, covering over 30 diseases including MS, RA, lupus, and Crohn's. Access deal terms, financials, and SEC contracts for top biopharma partnerships. A must-have for benchmarking, due diligence, and strategic planning in autoimmune R&D and commercialization. Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Autoimmune Collaboration and Licensing Deals 2016-2025" report has been added to Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the autoimmune deals entered into by the worlds leading biopharma revised and updated, the report provides details of 943 autoimmune deals from 2016 to report includes coverage of the following autoimmune diseases:Multiple sclerosis, Restless leg syndrome, Dermatitis, Eczema, Alopecia, Psoriasis, Celiac disease, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, Glomerulonephritis, Endometriosis, Immune thrombocytopenic purpura, Neutropenia, Graft versus host disease, Scleroderma, Systemic lupus erythematosus, Addison's disease, Diabetes Type 1, Ankylosing spondylitis, Juvenile arthritis, Psoriatic arthritis, Rheumatoid arthritis, Uveitis, Narcolepsy, Chronic obstructive pulmonary disease, Idiopathic pulmonary fibrosis, Sarcoidosis, Meniere's disease, and other autoimmune report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do report contains a comprehensive listing of collaboration and licensing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their initial chapters provide a valuable orientation to autoimmune dealmaking, beginning with an introduction in Chapter 1. Chapter 2 delves into trends within autoimmune dealmaking, offering a comprehensive analysis. The subsequent chapters provide detailed insights, covering the financial aspects of deals (Chapter 3), reviewing top active companies (Chapter 4), examining notable signed deals (Chapter 5), and presenting a directory organized by therapeutic target (Chapter 6).The report also includes numerous table and figures that illustrate the trends and activities in autoimmune deal making since addition, a comprehensive deal directory is provided organized by company A-Z and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on Collaboration and Licensing Deals provides the reader with the following key benefits: Understand deal trends since 2016 Browse autoimmune collaboration and licensing deals Benchmark analysis - identify market value of transactions Financials terms - upfront, milestone, royalties Directory of deals by company A-Z, therapy focus and technology type Leading deals by value Most active dealmakers Identify assets and deal terms for each transaction Access contract documents - insights into deal structures Due diligence - assess suitability of your proposed deal terms for partner companies Save hundreds of hours of research time Report ScopeAutoimmune Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of autoimmune trends and structure of deals entered into by leading biopharma companies Collaboration and Licensing Deals includes: Trends in autoimmune dealmaking in the biopharma industry Overview of collaboration and licensing deal structure Directory of autoimmune deal records covering pharmaceutical and biotechnology The leading autoimmune deals by value Most active autoimmune licensing dealmakers In Autoimmune Collaboration and Licensing Deals, the available deals are listed by: Company A-Z Headline value Therapeutic area Technology type Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where contract agreements allows due diligence of: What are the precise rights granted or optioned? What is actually granted by the agreement to the partner company? What exclusivity is granted? What is the payment structure for the deal? How are sales and payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Who is responsible for commercialization? Who is responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes to be resolved? Under what conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing and subcontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for agreement law? Key Topics Covered: Chapter 1 - IntroductionChapter 2 - Trends in autoimmune dealmaking2.1. Introduction2.2. Autoimmune deals over the years2.3. Autoimmune deals by deal type2.4. Autoimmune deals by industry sector2.5. Autoimmune deals by stage of development2.6. Autoimmune deals by technology typeChapter 3 - Financial deal terms for autoimmune deals3.1. Introduction3.2. Disclosed financials terms for autoimmune deals3.3. Autoimmune deal headline values3.4. Autoimmune deal upfront payments3.5. Autoimmune deal milestone payments3.6. Autoimmune deal royalty ratesChapter 4 - Leading autoimmune dealmakers and deals4.1. Introduction4.2. Most active in autoimmune dealmaking4.3. List of most active dealmakers in autoimmune4.4. Top autoimmune deals by valueChapter 5 - Autoimmune deal contract document directory5.1. Introduction5.2. Autoimmune partnering deals where contract document availableChapter 6 - Autoimmune dealmaking by therapeutic target6.1. Introduction6.2. Deals by autoimmune therapeutic targetDeal Directory Deal Directory - Autoimmune deals by company A-Z 2016 to 2025 Deal Directory - Autoimmune deals by technology type 2016 to 2025 A Selection of Companies Featured Include: AB Biosciences Abbott Laboratories Abbvie Acucela Aculys Pharma AdAlta Adhera Therapeutics Adimune Adiso Therapeutics Aditum Bio Aduro BioTech Adynxx Agility Life Sciences AimedBio Akaal Pharma Akebia Therapeutics Akouos Akston Biosciences Alex Therapeutics Alfasigma Alimentiv Alimera Sciences Alkermes Almirall AltaVoice Alvotech Amarna Therapeutics Ambiopharm Ambry Genetics Amegabiotech Amgen Amytrx Therapeutics AnaptysBio AnGes MG Anokion Anthem Bluecross AntibioTx Antidote Aptar Pharma Arbor Biotechnologies Arch Biopartners Arctic Vision Arcutis Biotherapeutics Arena Pharmaceuticals Aristea Therapeutics Ark Biosciences Aslan Pharma Aspect Biosystems Astellas Pharma Asthma UK AstraZeneca Astria Therapeutics Autolus Avacta Avalere Health Avicanna Axela Axoltis Pharma Axsome Therapeutics Azenta Life Sciences Azitra Bachem Back-A-Line Basilea Pharmaceutica Bausch & Lomb Bayer BCD Bioscience BenevolentAI Bennu Pharmaceuticals BGI Bigfoot Biomedical BinnoPharm Bio-Gate Bio-Path Bio-Rad Laboratories Bio-Techne BioClinica Biocon Biofourmis Biogen Bioqube Ventures Boehringer Ingelheim Boragen Boston Pharmaceuticals Brain Canada Brainomix Brickell Biotech Bristol-Myers Squibb C4X Discovery Cabaletta Bio Caladrius Biosciences Calliditas Therapeutics Candid Therapeutics Cantargia Cara Therapeutics CASI Pharmaceuticals Celltrion Celmatix Celsius Therapeutics Centessa Pharmaceuticals Centurion Century Therapeutics Charles River Laboratories CheckPoint Immunology Chugai Pharmaceutical Cipla Circassia Clearside Biomedical Clene Nanomedicine Cleveland Clinic ClinConnect Coeptis Therapeutics Collplant Conduit Pharmaceuticals Corrona Cosmofix Coya Therapeutics Cryostem CrystalGenomics CSL Behring Cugene Curant Health Cynata Therapeutics Cyrus Biotechnology Cytocom Daewoong Pharmaceutical Daiichi Sankyo Danuo Science Group Debiopharm Diurnal Diversigen DNAnexus Dr. Falk Pharma Dr. Reddy's Laboratories Dragonfly Therapeutics DreaMed Diabetes DyDo Pharma Editas Medicine EffRx Pharmaceuticals Eisai Eli Lilly ElsaLys Biotech Encore Dermatology Endo International Engitix Enosi Therapeutics Ensho Therapeutics Entera Health Enteris Biopharma Enzene Biosciences EOFlow Epicore Biosystems EpimAb Biotherapeutics epitoMAP Epivax Equillium Eterna Therapeutics Ethypharm EVA Pharma Evidation Health Evofem Biosciences Evolve BioSystems Evommune EVOQ Therapeutics Evotec Ewopharma Exagen Diagnostics Excelra Exscientia Fibrogen Fluidigm Fosun Pharmaceutical Frequency Therapeutics FSD Pharma Fujifilm Fuji Pharma FutureGen Biopharm G42 Healthcare Galderma GC Biopharma GenEdit Genentech Genetic Analysis Genmab Genomics Genprex GenScript ProBio Genten Therapeutics GentiBio Genzyme Georgiamune Giiant Pharma Gilead Sciences Glenmark Pharmaceuticals Graviton Bioscience GRI Bio GSK Gusto Global Gynica Halozyme Therapeutics Hansa Biopharma Haplogen Hesperos HIBio Hoffmann La Roche Honeywell Horizon Therapeutics Humanigen IMIDomics Immetas Therapeutics ImmPACT Bio Immugenyx ImmunoAdoptive Cell Therapy ImmunogenX Inception Sciences Incyte InDex Pharmaceuticals Inexia Innate Pharma Inserm Transfert InSilicoTrials Insmed Inc Integral Molecular Intract Pharma Intrexon Inventiva Ionis Pharmaceuticals IQVIA ISD Immunotech Iterative Scopes iTolerance Izana Bioscience Jackson Laboratory Janssen Biotech Jazz Pharmaceuticals Jiangsu Hansoh Pharmaceutical Johnson & Johnson Jolt Health JSR Jubilant Radiopharma Jubilant Therapeutics Jupiter Wellness JW Pharmaceutical Kadimastem Kadmon Pharmaceuticals Kaleido Biosciences Kamada KBI BioPharma Kezar Life Sciences Kindeva Drug Delivery Kiniksa Pharmaceuticals Kissei Pharmaceutical Kite Pharma Klue Komodo Health Koneksa Health Koye Pharmaceuticals Kubota Vision Landos Biopharma Lassen Therapeutics LEO Pharma Lexicon Pharmaceuticals LianBio Lipidor Lonza Lyfebulb LyGenesis Mabwell Bioscience mAbXience Mapi Pharma Marengo Therapeutics Maruho Max Biopharma Maxcyte Medac Medgenics Medimetriks Medison Pharma MedRhythms Medsenic Meiji Seika Merck and Co Metaba Microdrop Mimetas MiNA Therapeutics MiTest Health Moderna MorphoSys Mundipharma Mylan Laboratories Myovant Sciences Myriad Genetics Navidea Biopharmaceuticals Nektar Therapeutics Neogap Therapeutics Neoteryx Neovacs Neovii Pharmaceuticals Neurodon NeuroGenesis Nexel Nexilico Nippon Shinyaku Nitto Denko Nkarta Therapeutics NLS Pharmaceutics Nona Biosciences Nordic Pharma Group Novartis Novo Nordisk Nuance Pharma Nuevolution Numab Numares NuMedii Nutra Pharma Nxera Pharma Ocumension Therapeutics OliX Pharmaceuticals OMNY Health Orion Ossium Health Otsuka Paladin Labs Palisade Bio Palleon Pharmaceuticals Panaxia Pancryos Pandion Therapeutics Paragon Bioservices Parexel Biotech Parvus Therapeutics Patara Pharma PathoQuest Pearsanta Pediatrix Therapeutics Pelle Ventures Pfizer Pheno Therapeutics Philips PicnicHealth PlantEXT Pluristyx Pragma Bio Precision BioSciences PredictImmune Priovant Therapeutics Progenity Promius Pharma Propeller Health Protagen Protxx Purdue Pharma Quadri Pharmaceuticals Recipharm RedHill Biopharma Redx Pharma Regen BioPharma Regentys Regranion Relife Remedium Bio Renovion ReproCell RespirAI Medical Revive Therapeutics Revon Systems ReWalk Robotics Rheos Medicines Rigel Pharmaceuticals Roche Roivant Sciences RS BioTherapeutics Sandoz Sanguine Sanofi Sano Genetics Savana Scailyte Schrodinger Scienion Scipher Medicine Second Genome Selecta Biosciences Selexis Semma Therapeutics Sengenics Seres Therapeutics Sernova Serosep Shaperon Shire Laboratories Siemens Healthineers Sigilon Therapeutics Signum Biosciences Sirion Biotech Sitryx Skyhawk Therapeutics SomaLogic Sonde Health Sonoma BioTherapeutics Sorrento Therapeutics Statera Biopharma Surrozen SynAct Pharma Synaptogenix Syndax Pharmaceuticals Syneron Bio Synlogic Synthekine Synthonics Taiho Takara Bio Takeda Pharmaceutical Teva Pharmaceutical Industries TG Therapeutics Tharimmune Theradiag Theramex TiGenix Tiziana Life Sciences TONIX Pharmaceuticals Trethera True Diagnostics True North Therapeutics Truveta TxCell UCB UGA Biopharma Upsher-Smith Vaccinex Valo Health Variant Bio Vcell Healthcare Vectura Veracyte Verily Verona Pharma Versant Ventures Vicore Pharma Vital Therapies Vium Vivtex Voronoi Wanchunbulin WellDyne WuXi Biologics Xbrane Biopharma Xencor Xylyx Bio Zedira Zymeworks ZyVersa Therapeutics For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
PCR (qPCR, dPCR, Singleplex, Multiplex) Market Research Report 2025-2030 with Situation Analysis, Executives and Marketing Guide, & Investment Analysts and Management Consultants Guide
Explore the evolving PCR technology landscape with our comprehensive report. Discover market trends, including Singleplex and Multiplex testing, and the impact of digital PCR. Uncover investment opportunities in Point of Care Testing and Molecular Diagnostics. Gain insights with five-year forecasts and expert analysis. Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place Forecasting and Analysis" has been added to offering. This report provides comprehensive insights into how this convergence will shape future market dynamics, presenting critical information for industry stakeholders. The global landscape of disease diagnosis is undergoing a significant transformation, with PCR technology at its forefront. While the pandemic elevated PCR to a dominant position, ushering in a digital revolution within the sector, new markets and technologies are now emerging that may redefine diagnostics. This transition presents both opportunities and challenges for stakeholders. A newly released report offers an in-depth analysis of the market, featuring a five-year forecast that is uniquely segmented into Singleplex and Multiplex testing markets. PCR, which has showcased remarkable adaptability, gained widespread recognition as an essential tool in diagnostics. The advent of digital PCR further promises to enhance its efficacy, offering reduced costs and improved patient outcomes. Moreover, digital PCR stands as a powerful contender in combating Anti Microbial Resistance. For professionals seeking to leverage this data, the report is an indispensable resource that can transform executives into industry experts. It enables informed investment decisions and accurate company valuations, backed by the most current data available. With its detailed five-year market forecasts, the report equips organizations with the tools needed to strategically navigate this evolving landscape. In a market driven by innovation, understanding the nuances of these emerging technologies and their implications is crucial. This report encapsulates the trends, challenges, and opportunities that define the future of PCR technologies and diagnostics. Stay ahead of the curve by accessing the latest findings that will keep PCR at the core of disease detection and management globally. Discover how emerging diagnostics technology and market innovations are reshaping the competitive landscape. Access the full report today to explore untapped potential and prepare for the future of healthcare. Key Topics Covered: 1 Market Guides1.1 Situation Analysis1.2 Guide for Executives and Marketing Staff1.3 Guide for Investment Analysts and Management Consultants 2 Introduction and Market Definition2.1 What are PCR Technologies?2.2 PCR and Syndromic Testing2.3 Market Definition2.4 Methodology2.5 Perspective: Healthcare and the IVD Industry2.5.1 Global Healthcare Spending2.5.2 Spending on Diagnostics2.5.3 Important Role of Insurance for Diagnostics 3 PCR - Guide to PCR Technologies3.1 Concepts3.1.1 Method3.2 Applications3.2.1 Finding Specific DNA3.2.2 Measuring DNA3.2.3 Medical and Diagnostic Applications3.2.3.1 Carrier, prenatal and tissue typing3.2.3.2 Cancer Diagnosis and Management3.2.3.3 Infectious Disease - New Levels of Accuracy and Sensitivity3.2.3.4 Forensic Applications3.2.3.5 Science and Research3.3 PCR - Advantages and Disadvantages3.4 Different Types of PCR3.4.1 Simple Changes3.4.1.1 Multiplex-PCR3.4.1.2 VNTR PCR3.4.1.3 Asymmetric PCR3.4.1.4 Long PCR3.4.1.5 Nested PCR3.4.1.6 Quantitative PCR3.4.1.7 Hot-start PCR3.4.1.8 Touchdown PCR3.4.1.9 Assembly PCR3.4.1.10 Colony PCR3.4.1.11 Suicide PCR3.4.1.12 Cold PCR3.4.2 Digital PCR3.4.2.1 Droplet Digital PCR3.4.2.2 Comparison between dPCR and Real-Time PCR (qPCR)3.4.2.3 Digital PCR in Use3.4.2.4 Digital PCR Commercial History3.4.3 Isothermal PCR 4 Industry Overview4.1 Players in a Dynamic Market4.1.1 Academic Research Lab4.1.2 Diagnostic Test Developer4.1.3 Instrumentation Supplier4.1.4 Chemical/Reagent Supplier4.1.5 Pathology Supplier4.1.6 Independent Clinical Laboratory4.1.7 Public National/regional Laboratory4.1.8 Hospital Laboratory4.1.9 Physicians Office Lab (POLS)4.1.10 Audit Body4.1.11 Certification Body 5 Market Trends5.1 Factors Driving Growth5.1.1 A New Standard5.1.2 Down the Curve We Go5.1.3 Multiplexing5.1.4 Syndromic Diagnostics Looks Unstoppable5.1.5 The Genetic Blizzard5.2 Factors Limiting Growth5.2.1 The Cost Curve5.2.2 The Other Guys5.2.3 Systemic Roadblocks5.3 Diagnostic Technology Development5.3.1 The Instrumentation Curve5.3.2 Shifting Role of Diagnostics5.3.3 Diagnostics Moves Out of the Hospital5.3.4 Disruption Looms5.3.5 The Next Five Years 6 PCR Recent Developments6.1 Recent Developments - Importance and How to Use This Section6.1.1 Importance of These Developments6.1.2 How to Use This Section6.2 Seegene, Microsoft Collaborate for MDx Development6.3 QuidelOrtho Expanding Savanna Test Menu6.4 Binx Health Refocuses on POC STI Testing6.5 Qiagen, Myriad Genetics Partner to Develop Cancer Dx6.6 VedaBio Detecting Nucleic Acid With CRISPR6.7 Evvy Launches Add-on STI Screen6.8 ChromaCode Shifts to Oncology with dPCR Lung Cancer Test6.9 Multiplex Meningitis/Encephalitis Panel Market Expanding6.10 Sensible Dx to Launch 10-Minute POC PCR System6.11 ReadyGo Dx Plans to Make MDx Testing Easy6.12 Transformative Biotech Acquires Summit Biolabs' PCR Tech6.13 Visby Medical POC STI Multiplex Test Cleared6.14 Sherlock Biosciences Buys Sense Biodetection6.15 Agilent, Qiagen Nab FDA Approvals for Lung Cancer Treatment CDx6.16 HealthTrackRx Investing in Rapid Turnaround Times6.17 LEX Dx Developing Ultra-Fast Low-Cost PCR6.18 Next-Gen Dx Technologies Face Uncertain Future6.19 Rover Dx Developing All-Optical Rapid POC qPCR Platform6.20 ProtonDx Plans Rapid Molecular Dx Instrument6.21 Innova Medical Group Licenses MDx Tech6.22 MicroGEM to Grow Market for 30-Minute RT-PCR System6.23 Precipio Receives CE-IVD Mark for Cancer Panels6.24 Siemens Healthineers to Develop Next-Gen MDx Platform6.25 New York State Approves Enzo Biochem HPV Molecular Test6.26 Grip Molecular Developing Biosensor Panel to Detect Respiratory Infections6.27 Co-Diagnostics Seeks EUA for At-Home PCR Diagnostic System6.28 Chelex-Based Protocol to Reduce Cost, Time for PCR Testing6.29 Finnish Firms to Form Point-of-Care Testing Firm6.30 Visby Medical Scales Up Handheld PCR Test for STIs6.31 DnaNudge Raises $60M6.32 Roche Reports Diagnostics Revenue Up 51 Percent6.33 BforCure Preparing Multiple ID Panels for PoC qPCR Platform6.34 Enzo Biochem, CLX Health Partner for C19 Testing for Travel6.35 Bio Molecular Systems Gets Approval for Portable PCR Cycler6.36 Roche Acquires GenMark6.37 Handheld qPCR Devices Close to Commercialization6.38 Nuclein Closes $14M in Funding6.39 WuXi Diagnostics Closes $150M Series B Financing Round6.40 Visby Medical to develop rapid Flu-COVID PCR test6.41 Thermo Fisher to Acquire Mesa Biotech 7 Profiles of Key PCR Companies7.1 Abbott Laboratories7.2 Accelerate Diagnostics7.3 Ador Diagnostics7.4 ADT Biotech7.5 Agilent7.6 Akonni Biosystems7.7 Altona Diagnostics7.8 Alveo Technologies7.9 Amoy Diagnostics Co., Ltd.7.10 Anatolia Geneworks7.11 Applied BioCode7.12 Applied DNA Sciences7.13 Aurora Biomed7.14 Aus Diagnostics7.15 AVIVA Systems Biology7.16 Beckman Coulter Diagnostics (Danaher)7.17 Becton, Dickinson and Company7.18 Binx Health7.19 Biocartis7.20 bioMerieux Diagnostics7.21 Bioneer Corporation7.22 Bio-Rad Laboratories, Inc7.23 Bosch Healthcare Solutions GmbH7.24 Bruker7.25 Caris Molecular Diagnostics7.26 Cepheid (Danaher)7.27 Credo Diagnostics Biomedical7.28 CTK Biotech7.29 Cue Health7.30 Curetis (OpGen)7.31 Diagenode Diagnostics (Hologic)7.32 Diasorin S.p.A.7.33 Eiken Chemical7.34 Enzo Biochem7.35 Eurofins Scientific7.36 Fluxergy7.37 Fujirebio7.38 Genetic Signatures7.39 GenMark Dx (Roche)7.40 Greiner Bio-One7.41 Hologic7.42 Immunexpress7.43 Inflammatix7.44 Invetech7.45 J&J Innovative Medicine7.46 Karius7.47 LumiraDx7.48 Maxim Biomedical7.49 Meridian Bioscience7.50 Millipore Sigma7.51 Molbio Diagnostics7.52 Nanomix7.53 NGeneBio7.54 Novacyt7.55 Nuclein7.56 Operon7.57 Panagene7.58 Precipio7.59 Primerdesign (Novacyt)7.60 Promega7.61 Prominex7.62 Qiagen7.63 QuantuMDx7.64 QuidelOrtho7.65 Randox Toxicology7.66 R-Biopharm AG7.67 Revvity7.68 Roche Diagnostics7.69 Scope Fluidics7.70 SD Biosensor7.71 Seegene7.72 Siemens Healthineers7.73 SkylineDx7.74 Sona Nanotech7.75 SpeeDx7.76 Standard BioTools7.77 Stilla Technologies7.78 Streamline Scientific7.79 T2 Biosystems7.80 Thermo Fisher Scientific7.81 Uniogen7.82 Vela Diagnostics7.83 Veramarx7.84 Veredus Laboratories7.85 Vircell7.86 Visby Medical7.87 XCR Diagnostics7.88 YD Diagnostics7.89 Zhejiang Orient Gene Biotech 8 The Global PCR Markets8.1 PCR - Global Market Overview by Country8.2 Global Market by Application - Overview8.3 Global Market by Technology - Overview8.4 Global Market by Product - Overview8.5 Global Market by Place - Overview 9 Global PCR Markets - By Application9.1 PCR Clinical Multiplex9.2 PCR Clinical Singleplex9.3 PCR Research 10 Global PCR Markets - By Technology10.1 qPCR10.2 dPCR 11 Global PCR Markets - By Product11.1 PCR Instruments11.2 PCR Nucleic Acid Extraction11.3 PCR Consumables11.4 PCR Services 12 Global PCR Markets - By Place12.1 PCR Clinical Laboratory12.2 PCR Point of Care12.3 PCR Commercial12.4 PCR Pharmaceutical 13 Appendices13.1 Growth of Approved IVD Test Menu13.2 Growth of Approved Average IVD Test Fee13.3 The Most Used IVD Assays13.4 The Highest Grossing Assays13.5 Laboratory Fees Schedule For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
USA Today
an hour ago
- USA Today
How long does a cold last? And how long are you contagious?
Many people think of December and January as the two months of the year you're likely to catch the common cold, but 'cold season' actually stretches from late August through April. That means only about three months of the year, typically May through July, fall outside it. But even during these 'off' months, nearly one in 10 people still catch a cold, according to data from the U.S. Centers for Disease Control and Prevention. In other words, in any given month, tens of millions of people are walking around with telltale cold symptoms like a stuffy nose, headache, fatigue, sneezing, sore throat and sometimes a cough or low-grade fever. Here's what causes colds to spread so easily, how long they are usually contagious and how they're most commonly treated. What are the main causes of a cold? The common cold is most often caused by a viral infection. Rhinoviruses are the leading culprit, but other viruses such as adenoviruses, certain coronaviruses, respiratory syncytial virus (RSV) and parainfluenza viruses can also trigger cold symptoms by infecting the upper respiratory tract. Need a break? Play the USA TODAY Daily Crossword Puzzle. These and more than 200 other viruses spread through saliva or mucus particles expelled from a sick person. 'To catch a cold, you must introduce a cold virus from someone else into your airway,' says Dr. David Hill, a North Carolina-based pediatrician and spokesperson for the American Academy of Pediatrics. This typically happens when infected respiratory droplets are released into the air when a sick person talks, sings, sneezes or coughs. In addition to being inhaled directly, viruses can also land on surfaces and spread when someone touches a contaminated surface and then brushes their nose, eyes or mouth. 'Being in shared spaces often increases the likelihood of transmission,' says Dr. Alison Mitzner, a New York City-based board-certified pediatrician and author of "Calm and Confident Parenting." Other risk factors include a weakened immune system, preexisting health conditions, exposure to cigarette smoke, colder months with lower humidity (which dry out nasal passages) and aging. "Sleep deprivation and fatigue can also make people more susceptible to catching a cold," adds Hill. How long are colds contagious? One of the reasons colds spread so frequently is that they are contagious even before symptoms begin, often one or two days beforehand. After that, "you're usually contagious for as long as you have symptoms, which typically last seven to ten days," says Mitzner. While germs can spread anytime throughout this period, the most viral shedding tends to happen around days four to six. "Know that you can remain contagious for up to two weeks though," she adds. Hill says it's also important to note that "different cold viruses have different levels of contagion." RSV, for example, "is extraordinarily easy to transmit at it can survive on surfaces for hours," he explains. Yes, pneumonia can be contagious. But here's why it depends on the form. How are colds treated? While symptoms can almost always be managed, 'there are no treatments that shorten the duration of a cold,' says Hill. Instead, "every cold just needs to run its course," says Mitzner. To relieve symptoms in the meantime, Hill recommends saltwater nasal rinses for congestion or using nasal decongestants like oxymetazoline if symptoms are especially bad. But he cautions against using them for more than two to three days due to the risk of rebound congestion which, he says, "may be worse than the cold itself." Medications such as acetaminophen or ibuprofen can also reduce fever and alleviate sore throat or headaches but should not be given to very young children without medical advice. For younger kids, Hill recommends honey as a natural cough and sore throat remedy, though he emphasizes that infants and kids under 1 year should never be given honey due to the risk of botulism. 'When you catch a cold, it's important to let your body heal,' says Mitzner. That means rest, hydration and the use of 'a cool-mist humidifier at night to breathe easier.'
